| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $5.4M | -9.5% |
| SG&A Expense | $6.0M | +45.3% |
| Operating Income | -$11.4M | -12.8% |
| Interest Expense | $194K | — |
| Income Tax | $0 | — |
| Net Income | -$12.9M | -31.1% |
| EPS (Diluted) | -$12.52 | -310.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $600K | — |
| Current Assets | $695K | -72.8% |
| Total Assets | $2.8M | -40.4% |
| Current Liabilities | $4.0M | +128.2% |
| Total Liabilities | $4.1M | +121.2% |
| Stockholders' Equity | -$1.3M | -144.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.5M | -2.0% |
| Investing Cash Flow | -$62K | -100.8% |
| Financing Cash Flow | $6.9M | +6031.3% |